Nobuo Tsuchida, Masa-Aki Ikeda, Υoshizumu Ιshino, Michele Grieco, Giancarlo Vecchio. FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status. International Journal of Oncoloy. 2017.06; 50 (6): 2043-2048. ( PubMed, DOI )

Endrawan Pratama, Xiaohui Tian, Widya Lestari, Sachiko Iseki, Solachuddin J A Ichwan, Masa-Aki Ikeda. Critical role of ARID3B in the expression of pro-apoptotic p53-target genes and apoptosis. Biochem. Biophys. Res. Commun.. 2015.12; 468 (1-2): 248-254. ( PubMed, DOI )

Yayoi Ikeda, Masa-Aki Ikeda. Cyclin E marks quiescent neural stem cells and caspase-3-positive newborn cells during adult hippocampal neurogenesis in mice. Neurosci. Lett.. 2015.10; 607 90-96. ( PubMed, DOI )

Eri Tsuchida, Atsushi Kaida, Endrawan Pratama, Masa-Aki Ikeda, Keiji Suzuki, Kiyoshi Harada, Masahiko Miura. Effect of X-Irradiation at Different Stages in the Cell Cycle on Individual Cell-Based Kinetics in an Asynchronous Cell Population. PLoS ONE. 2015; 10 (6): e0128090. ( PubMed, DOI )

Solachuddin J A Ichwan, Imad M Al-Ani, Hakim G Bilal, Wastuti H Suriyah, Muhammad Taher, Masa-Aki Ikeda. Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines. Chin J Physiol. 2014.10; 57 (5): 249-255. ( PubMed, DOI )

Yuniardini S Wimardhani, Dewi F Suniarti, Hans J Freisleben, Septelia I Wanandi, Nurjati C Siregar, Masa-Aki Ikeda. Chitosan exerts anticancer activity through induction of apoptosis and cell cycle arrest in oral cancer cells. J Oral Sci. 2014.06; 56 (2): 119-126. ( PubMed )

Auerkari E I, Joewono V, Handjari D R, Sarwono A T, Suhartono A W, Eto K, Ikeda M A. Expression of p27Kip1 and E-cadherin in Head and Neck Squamous Cell Carcinoma of Indonesian Patients. Open Dent J. 2014; 8 136-143. ( PubMed, DOI )

Young Min Chung, See-Hyoung Park, Wen-Bin Tsai, Shih-Ya Wang, Masa-Aki Ikeda, Jonathan S Berek, David J Chen, Mickey C-T Hu. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. Nat Commun. 2012.08; 3 1000. ( PubMed, DOI )

Wimardhani SY, Sunia DF, Freisleben H-J, Septelia Wanandi SI, Ikeda MA. Cytotoxic effect of chitosan against oral cancer cell lines is molecular-weight-dependent and cell-type-specific. Int. J. Oral Res. 2012.04; 3 e1.

Teng Ma, Shumpei Yamada, Solachuddin J A Ichwan, Sachiko Iseki, Kiyoshi Ohtani, Megumi Otsu, Masa-Aki Ikeda. Inability of p53-reactivating compounds Nutlin-3 and RITA to overcome p53 resistance in tumor cells deficient in p53Ser46 phosphorylation. Biochem. Biophys. Res. Commun.. 2012.01; 417 (3): 931-937. ( PubMed, DOI )

Widya Lestari, Solachuddin J A Ichwan, Megumi Otsu, Shumpei Yamada, Sachiko Iseki, Shihoko Shimizu, Masa-Aki Ikeda. Cooperation between ARID3A and p53 in the transcriptional activation of p21WAF1 in response to DNA damage. Biochem. Biophys. Res. Commun.. 2012.01; 417 (2): 710-716. ( PubMed, DOI )

Yayoi Ikeda, Yuko Matsunaga, Masahito Takiguchi, Masa-Aki Ikeda. Expression of cyclin E in postmitotic neurons during development and in the adult mouse brain. Gene Expr. Patterns. 2011.01; 11 (1-2): 64-71. ( PubMed, DOI )

Juan Liu, Hiroshi Uematsu, Nobuo Tsuchida, Masa-Aki Ikeda. Essential role of caspase-8 in p53/p73-dependent apoptosis induced by etoposide in head and neck carcinoma cells. Mol. Cancer. 2011; 10 95. ( PubMed, DOI )

Liu J, Uematsu H, Tsuchida N, Ikeda MA. Association of caspase-8 mutation with chemoresistance to cisplatin in HOC313 head and neck squamous cell carcinoma cells. Biochem Biophys Res Commun. 2009.12; 390 (3): 989-994. ( PubMed, DOI )

Ichwan SJA, Ikeda MA. Defect in Ser46 Phosphorylation of p53 Protein: A Resistance Mechanism against p53 Gene Transfer in Oral Squamous Cell Carcinoma Cells . J Oral Biosci. 2009.10; 50 (2): 98-106. ( DOI )

Murugan AK, Hong NT, Cuc TT, Hung NC, Munirajan AK, Ikeda MA, Tsuchida N. Detection of two novel mutations and relatively high incidence of H-RAS mutations in Vietnamese oral cancer. Oral Oncol. 2009.10; 45 (10): e161-6. ( PubMed, DOI )

Althunibat OY, Hashim, RB, Taher M, Daud JM, Ikeda MA, Zali BI. n Vitro Antioxidant and Antiproliferative Activities of Three Malaysian Sea Cucumber Species. European Journal of Scientific Research . 2009.04; (37): 376-387.

Ozono E, Komori H, Iwanaga R, Ikeda MA, Iseki S, Ohtani K. E2F-like elements in p27(Kip1) promoter specifically sense deregulated E2F activity. Genes Cells. 2009.01; 14 (1): 89-99. ( PubMed, DOI )

Suganuma T, Ikeda MA. Tumor Growth Suppression by the Coactivator p300 . J Oral Biosci. 2008.10; 50 (2): 115-124. ( DOI )

Iwanaga R, Ozono E, Fujisawa J, Ikeda MA, Okamura N, Huang Y, Ohtani K. Activation of the cyclin D2 and cdk6 genes through NF-kappaB is critical for cell-cycle progression induced by HTLV-I Tax. Oncogene. 2008.05; ( PubMed, DOI )

Katsuki Y, Sakamoto K, Minamizato T, Makino H, Umezawa A, Ikeda MA, Perbal B, Amagasa T, Yamaguchi A, Katsube K. Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1. Biochem Biophys Res Commun. 2008.04; 368 (3): 808-814. ( PubMed, DOI )

Ichwan, SJA, Ikeda MA. Defect in Ser46 Phosphorylation of p53 Protein: A Resistance Mechanism against p53 Gene Transfer in Oral Squamous Cell Carcinoma Cells. J. Oral Biosci.. 2008; 50 (2): 98-106.

Nakajima Y, Yamada S, Kamata N, Ikeda MA. Interaction of E2F-Rb family members with corepressors binding to the adjacent E2F site. Biochem Biophys Res Commun. 2007.12; 364 (4): 1050-1055. ( PubMed, DOI )

Bhawal UK, Sugiyama M, Nomura Y, Sawajiri M, Tsukinoki K, Ikeda MA, Kuniyasu H. High-risk human papillomavirus type 16 E7 oncogene associates with Cdc25A over-expression in oral squamous cell carcinoma. Virchows Arch. 2007.01; 450 (1): 65-71. ( PubMed, DOI )

Ichwan SJ, Yamada S, Sumrejkanchanakij P, Ibrahim-Auerkari E, Eto K, Ikeda MA. Defect in serine 46 phosphorylation of p53 contributes to acquisition of p53 resistance in oral squamous cell carcinoma cells. Oncogene. 2006.02; 25 (8): 1216-1224. ( PubMed, DOI )

Sumrejkanchanakij P, Eto K, Ikeda MA. Cytoplasmic sequestration of cyclin D1 associated with cell cycle withdrawal of neuroblastoma cells. Biochem Biophys Res Commun. 2006.02; 340 (1): 302-308. ( PubMed, DOI )

Bhawal UK, Ozaki Y, Nishimura M, Sugiyama M, Sasahira T, Nomura Y, Sato F, Fujimoto K, Sasaki N, Ikeda MA, Tsuji K, Kuniyasu H, Kato Y. Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma. Oncology. 2005; 69 (3): 246-255. ( PubMed, DOI )

Yamada S, Sumrejkanchanakij P, Amagasa T, Ikeda MA. Loss of cyclin E requirement in cell growth of an oral squamous cell carcinoma cell line implies deregulation of its downstream pathway. Int J Cancer. 2004.08; 111 (1): 17-22. ( PubMed, DOI )

Nonomura Y, Kohsaka H, Nagasaka K, Miyasaka N. Gene transfer of a cell cycle modulator exerts anti-inflammatory effects in the treatment of arthritis. J Immunol. 2003.11; 171 (9): 4913-4919. ( PubMed )

Ikeda Y, Nagai A, Ikeda MA, Hayashi S. Sexually dimorphic and estrogen-dependent expression of estrogen receptor beta in the ventromedial hypothalamus during rat postnatal development. Endocrinology. 2003.11; 144 (11): 5098-5104. ( PubMed, DOI )

Sumrejkanchanakij P, Tamamori-Adachi M, Matsunaga Y, Eto K, Ikeda MA. Role of cyclin D1 cytoplasmic sequestration in the survival of postmitotic neurons. Oncogene. 2003.11; 22 (54): 8723-8730. ( PubMed, DOI )

Araki K, Nakajima Y, Eto K, Ikeda MA. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter. Oncogene. 2003.10; 22 (48): 7632-7641. ( PubMed, DOI )

Ma K, Araki K, Ichwan SJ, Suganuma T, Tamamori-Adachi M, Ikeda MA. E2FBP1/DRIL1, an AT-rich interaction domain-family transcription factor, is regulated by p53. Mol Cancer Res. 2003.04; 1 (6): 438-444. ( PubMed )

Nagai A, Ikeda Y, Aso T, Eto K, Ikeda MA. Exposure of neonatal rats to diethylstilbestrol affects the expression of genes involved in ovarian differentiation. J Med Dent Sci. 2003.03; 50 (1): 35-40. ( PubMed )

Tamamori-Adachi M, Ito H, Sumrejkanchanakij P, Adachi S, Hiroe M, Shimizu M, Kawauchi J, Sunamori M, Marumo F, Kitajima S, Ikeda MA. Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation. Circ Res. 2003.01; 92 (1): e12-9. ( PubMed )

Suganuma T, Kawabata M, Ohshima T, Ikeda MA. Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator. Proc Natl Acad Sci U S A. 2002.10; 99 (20): 13073-13078. ( PubMed, DOI )

Tamamori-Adachi M, Ito H, Nobori K, Hayashida K, Kawauchi J, Adachi S, Ikeda MA, Kitajima S. Expression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophy. Biochem Biophys Res Commun. 2002.08; 296 (2): 274-280. ( PubMed )

29. Gao CF, Ren S, Wang J, Zhang SL, Jin F, Nakajima T, Ikeda MA, Tsuchida N. . P130 and its truncated form mediate p53-induced cell cycle arrest in Rb-/- Saos2 cells. Oncogene. 2002.04; (21): 7569-7579.

Ikeda Y, Nagai A, Ikeda MA, Hayashi S. Increased expression of Mullerian-inhibiting substance correlates with inhibition of follicular growth in the developing ovary of rats treated with E2 benzoate. Endocrinology. 2002.01; 143 (1): 304-312. ( PubMed )

Ikeda Y, Nagai A, Ikeda MA, Hayashi S. Neonatal estrogen exposure inhibits steroidogenesis in the developing rat ovary. Dev Dyn. 2001.08; 221 (4): 443-453. ( PubMed, DOI )

Zhang YW, Morita I, Ikeda M, Ma KW, Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene. 2001.07; 20 (31): 4138-4149. ( PubMed, DOI )

Nonomura Y, Kohsaka H, Nasu K, Terada Y, Ikeda M, Miyasaka N. Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p21(Cip1) gene into the joints. Int Immunol. 2001.06; 13 (6): 723-731. ( PubMed )

Adachi S, Ito H, Tamamori-Adachi M, Ono Y, Nozato T, Abe S, Ikeda Ma, Marumo F, Hiroe M. Cyclin A/cdk2 activation is involved in hypoxia-induced apoptosis in cardiomyocytes. Circ Res. 2001.03; 88 (4): 408-414. ( PubMed )

Matsui M, Ikeda M, Akatsuka T. High expression of HLA-A2 on an oral squamous cell carcinoma with down-regulated transporter for antigen presentation. Biochem Biophys Res Commun. 2001.02; 280 (4): 1008-1014. ( PubMed, DOI )

Ohshima T, Suganuma T, Ikeda M. A novel mutation lacking the bromodomain of the transcriptional coactivator p300 in the SiHa cervical carcinoma cell line. Biochem Biophys Res Commun. 2001.02; 281 (2): 569-575. ( PubMed, DOI )

Ohtani K, Iwanaga R, Nakamura M, Ikeda M, Yabuta N, Tsuruga H, Nojima H. Cell growth-regulated expression of mammalian MCM5 and MCM6 genes mediated by the transcription factor E2F. Oncogene. 1999.04; 18 (14): 2299-2309. ( PubMed, DOI )

Tamamori M, Ito H, Hiroe M, Terada Y, Marumo F, Ikeda MA. Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy. Am J Physiol. 1998.12; 275 (6 Pt 2): H2036-40. ( PubMed )

Ota M, Eto K, Ninomiya Y, Ikeda M. Accumulation of p300 mediates transcriptional repression of simian virus 40 enhancer in undifferentiated F9 embryonal carcinoma cells. Cell Growth Differ. 1998.12; 9 (12): 989-997. ( PubMed )

Ohtani K, Tsujimoto A, Ikeda M, Nakamura M. Regulation of cell growth-dependent expression of mammalian CDC6 gene by the cell cycle transcription factor E2F. Oncogene. 1998.10; 17 (14): 1777-1785. ( PubMed, DOI )

Chareonvit S, Osumi-Yamashita N, Ikeda M, Eto K. Murine forebrain and midbrain crest cells generate different characteristic derivatives in vitro. Dev Growth Differ. 1997.08; 39 (4): 493-503. ( PubMed )

Ikeda MA, Jakoi L, Nevins JR. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc Natl Acad Sci U S A. 1996.04; 93 (8): 3215-3220. ( PubMed )

Ikeda MA, Nevins JR. Identification of distinct roles for separate E1A domains in disruption of E2F complexes. Mol Cell Biol. 1993.11; 13 (11): 7029-7035. ( PubMed )

Yamada S, Ikeda MA, and Eto, K.. Differential Expression of c-myc and N-myc during Oral Organogenesis of the Mouse Embryo. Dev. Growth Differ.. 1992; (34): 239-251.

Nakajima H, Ikeda M, Tsuchida N, Nishimura S, Taya Y. Inactivation of the N-myc gene product by single amino acid substitution of leucine residues located in the leucine-zipper region. Oncogene. 1989.08; 4 (8): 999-1002. ( PubMed )

Suzuki Y, Hidari K, Matsumoto M, Ikeda M, Tsuchida N. Altered ganglioside expression in ras-oncogene-transformed cells. J Biochem. 1989.07; 106 (1): 34-37. ( PubMed )

Ikeda M, Tsuchida N. Myc genes linked to viral promoters can collaborate with a transformation-deficient simian virus 40 early gene mutant to transform established rat cells. Jpn J Cancer Res. 1987.05; 78 (5): 428-431. ( PubMed )

Parlayan Cuneyd, Sahin Yunus, Altan Zekiye, Arman Kaifee, Ikeda Masa-Aki, Saadat Khandakar A. S. M.. ARID3A regulates autophagy related gene BECN1 expression and inhibits proliferation of osteosarcoma cells BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2021.12; 585 89-95. ( PubMed, DOI )

Zhang K, Ikeda Y, Kasugai S, Ikeda MA. Extended Culture Conditions for Multipotent Bone Marrow-Derived Mesenchymal Stem Cells 口腔病学会雑誌. 2016.03; 83 (1): 13-23.

池田正明. 口腔癌におけるp53遺伝子導入抵抗性獲得の分子機構 口腔病学会雑誌. 2006; 73 (1): 139.

池田正明. 増えない細胞の細胞周期研究 —組織再生と細胞死— 2004; 22 (13): 1820-1824.

池田正明. RB蛋白質 炎症と免疫. 2003; (8): 122-123.

池田正明、安達三美. サイクリンＤ１の核移行制御と心筋細胞の増殖 実験医学. 2003; 21 (5): 37-42.

池田正明. 転写因子E2F-RBファミリーとDNA腫瘍ウイルスのターゲット 転写因子E2Fと細胞増殖制御 実験医学. 1995; (13): 126-131.

丸山光男、和賀祥、和田忠志、池田正明、松本健蛋白質核酸酵素. DNA腫瘍ウイルスの分子生物学の現状 蛋白質核酸酵素. 1994; (39): 252-261.

佐竹正延、池田正明、沢田幸治、和田忠士、村上康文. SV40, ポリオーマ、アデノウイルスの分子生物学ー最近の動向 蛋白質核酸酵素. 1991; (36): 910-918.

大谷清、池田正明. 転写因子E2Fと細胞増殖制御 蛋白質核酸酵素. 1987.04; 42 (10): 1603-1611.

増えない細胞の細胞周期研究 —組織再生と細胞死-　実験医学 Vol.22 No.13 p. 1820-1824. 羊土社, 2004 (ISBN : 9784897068282)

サイクリンＤ１の核移行制御と心筋細胞の増殖　実験医学、Vol.21, No.5 (増刊), p37-42. 羊土社, 2003 (ISBN : 9784897060965)

Bタンパク質と転写因子E2Fによる細胞周期の制御機構　「わかる細胞周期と癌」 p28-36 ISBN : 9784897065755. 羊土社, 2000

Bタンパク質と転写因子E2Fによる細胞周期の制御機構　「わかる細胞周期と癌　田矢洋一編」 p28-36. 羊土社, 2000 (ISBN : 9784897065755)

新しい発光システムを応用したマルチレポーターアッセイ　—　ルシフェラーゼアッセイによる転写活性測定法とその応用　「脱アイソトープ実戦プロトコール（２）」　p334-346. 秀潤社, 1998 (ISBN : 87962-181-1)

転写因子E2Fと細胞増殖制御　蛋白質 核酸 酵素 （増刊）　Vol. 42 No. 10 p1603-1611. 共立出版, 1997

Saadat K ASM, Arman K, Ikeda MA. ARID3A Directly Regulates Autophagy Related Gene Beclġn1 in Osteosarcoma. 2nd ZEUGMA International Congress on Multidisciplinary Studies 2019.01.18 Gaziantep Turkey

Arman K, Saadat K ASM, Altan Z, Sahin Y, Ikeda MA, Igci M. Opposite roles of lncRNA ERICD and ARID3A in DNA damage-induced apoptosis. 5th World Congress on Epigenetics and Chromosome 2018.11.15

Altan Z, Şahin Y, Yassin AR, Ikeda MA, Saadat K ASM. The Interaction betweeen LncRNA MEG3 and its Target, miR-203, in Bladder Cancer. International Eurasian Conference on Biological and Chemical Sciences 2018.04.26 Ankara, Turkey

Xiaohui Tian、Shohei Kasugai、Masa-Aki Ikeda. Investigation of culture conditions for enhancing the proliferation and osteogenic differentiation potential of adipose-derived stem cells. 2017年度生命科学系学会合同年次大会 2017.12.07

3. Nobuo Tsuchida, Alessia Parascandolo, Masa-Aki Ikeda, Maria D Castellone, Giancarloa Vecchio. p53-inducible FUCA1 attenuates aggressiveness of thyroid and breast cancers. 第76回日本癌学会学術総会 2017.09.28

Amani KANJO , Kaifee ARMAN , Ahmet ARSLAN , Sibel Oğuzkan BALCI , Masa-Aki IKEDA , Khandakar A S M SAADAT. ARID3A Directly Regulates AKT1 But Not PTEN In Osteosarcoma. 1st International Congress on Cancer & Ion Channels 2017.09.21

土田 信夫, パラスカンドロ・アレッシア , 池田 正明, カステローネ・マリア , ベッキオ・ジャンカルロ . p53誘導FUCA1遺伝子は甲状腺がん、乳がんの悪性度を減弱する. 日本癌学会総会記事 2017.09.01

Bozgeyik I, Çakmak EA, Saadat KASM, Ikeda MA, Igci M. Microtubule Associated Scaffold Protein 1 (MTUS1) is A Candidate Tumor Suppressor in Breast Cancer. VI. International Congress of Molecular Medicine 2017.05.22

Ikeda MA. Novel Candidates of Therapeutic Targets for Head and Neck Squamous Cell Carcinomas Defined by Recent Comprehensive Mutation Analysis . The 17th Scientific and Refresher Course in Dentistry (KPPIKG 2016) 2016.02.27 Jakarta, Indonesia

Endrawan Pratama, Khandakar A S M Saadat，Widya Lestari，Solachuddin J. A. Ichwan, Sachiko Iseki, Kiyoshi Ohtani，Masa-Aki Ikeda. ARID3B promotes gene expression critical for E2f-mediated cell cycle progression and p53-mediated apotosis. Biochemistry and Molecular Biology (BMB2015) 2015.12.01 Kobe

Saadat Khandakar Asm, Arman Kaifee, Arslan Ahmet, Sachiko Iseki, Kiyoshi Ohtani, Masa-Aki Ikeda. Expression study of E2F-target genes in osteosarcoma (U2OS) and glioblastoma (T98G) cell lines after knocking down ARID3A and ARID3B. XIV. National Congress of Medical Biology and Genetics 2015.10.27 Fethiye, Turkey

Saadat Khandakar Asm, Arman Kaifee, Arslan Ahmet, Kiyoshi Ohtani, Masa-Aki Ikeda. Overexpression of ARID3 facilitates E2F-dependent apoptosis. XIV. National Congress of Medical Biology and Genetics 2015.10.27

Ikeda, MA. Simple and efficient long-term culture method to maintain multipotent differentiation potential of mesenchymal stem/stromal cells. Seminar 2015.03.27 Kuantan, Malaysia

Ikeda Y, Ikeda MA. Immunohistochemical detection of cyclin E in non-proliferating neurons of the mouse adult hippocampal dentate gyrus. Society for Neuroscience 2014 Annual Meeting 2014.11.17

Ikeda, MA. Mesenchymal Stem Cells and Bone Tissue Engineering - Overview and Our Approach –. Regional Oral Biology Scientific Meeting 2014 2014.10.30

山崎新太郎，清水 真優，井関 祥子，依田 哲也，池田 正明. 軟骨内骨化を介した骨再生に適したヒト間葉系幹細胞の培養条件および足場材料の検討. 第42回日本炎症・再生医学会 2021.07.07 東京

Saadat KASM，Pratama E, Lestari W，Ma T, Ohtani K，Ikeda MA. Critical role of ARID3B in the expression of E2F-responsive genes and cell proliferation. 第39回日本分子生物学会年会 2016.12.01 横浜

Zhang K, Kasugai S, Ikeda MA. Maintenance of Stemness in Mesenchymal Stem Cells during Long-Term Culture. 第79回口腔病学会学術大会 2014.12.06

Pratama E, Iseki S, Ikeda MA. Critical roles for ARID3B in Expression of Proapoptotic p53-Target Genes and Cell Death Following DNA Damage. 第 37回日本分子生物学会年会 2014.11.26

Endrawan Pratama、井関祥子、池田正明. アポトーシス関連p53標的遺伝子の発現と細胞死誘導におけるDNA結合因子ARID3Bの重要な役割. 第56回歯科基礎医学会学術大会 2014.09.13